Risk in drug trials

Lancet. 2006 Dec 23;368(9554):2205-6. doi: 10.1016/S0140-6736(06)69883-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal / metabolism*
  • Antibodies, Monoclonal, Humanized
  • CD28 Antigens / metabolism*
  • Humans
  • Macaca
  • Species Specificity
  • Structure-Activity Relationship

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CD28 Antigens
  • TGN-1412